Publication:
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.

Loading...
Thumbnail Image

Date

2022

Authors

Busca, Alessandro
Salmanton-García, Jon
Corradini, Paolo
Marchesi, Francesco
Cabirta, Alba
Di Blasi, Roberta
Dulery, Remy
Lamure, Sylvain
Farina, Francesca
Weinbergerová, Barbora

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.

Description

MeSH Terms

COVID-19
Humans
Immunotherapy, Adoptive
Receptors, Chimeric Antigen
T-Lymphocytes

DeCS Terms

CIE Terms

Keywords

Citation